Anthem Biosciences

India
Small Molecule API Peptides & Oligos Biologics
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ✓ Press (11) ○ EMA GMP ○ MHRA GMP ✓ HC GMP (3)

Quick Facts: Anthem Biosciences

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
India
Website
Modalities
Small Molecule API, Peptides & Oligos, Biologics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Anthem Biosciences

Anthem Biosciences is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Peptides & Oligos, Biologics. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://anthembio.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Anthem Biosciences FDA Inspection History

2025-01
NAI VAI OAI
Date Site Type Observations Classification
2025-01-24
Anthem Biosciences Limited
Bengaluru Facility-linked
Drug Quality Assurance No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 11 articles

Company announcements, not verified evidence. They do not change any score.
news Wed, 26 No
Divi’s, Syngene & Laurus: 6 stocks JPMorgan says will lead India’s $15.4 billion CRDMO boom - financialexpress.com
news Wed, 16 Ju
Anthem Biosciences IPO GMP surges as Rs 3,395-crore issue subscribed 64 times on Day 3 - Moneycontrol.com
news Wed, 10 Ju
Pharma stocks that could deliver up to 167% return: Macquarie, Jefferies, JP Morgan top picks - zeebiz.com
news Wed, 08 Ja
Indian CDMO Anthem Biosciences files for $397M IPO amid expansion efforts - Fierce Pharma
news Tue, 15 Ju
Anthem Biosciences IPO: A solid CDMO story, but don’t expect fireworks - Moneycontrol.com
news Thu, 10 Ju
IPO-bound Anthem Bio says cost arbitrage drove expansion, proposing China alternative for global pharma - Moneycontrol.com
news Sun, 20 Ju
CDMOs gear up for peptide boom amid rising demand for weight-loss drugs - Business Standard
news Sat, 15 Au
Pharma Stocks Rally After Earnings: Where Is The Value Across CDMO And Healthcare? - Business Today
news Mon, 28 Ju
Indian contract drug makers timed their IPOs right. But is the business worth the premium? - livemint.com
general 2026-10-12
Anthem Biosciences (NSEI:ANTHEM) Stock Price - Simply Wall Street
Anthem Biosciences (NSEI:ANTHEM) Stock Price  Simply Wall Street
general 2026-10-07
Anthem Biosciences (ANTHEM.NS) Slips 0.61% to ₹884.95, Holding Firmly Above ₹840.7 Support - Short Setup Alerts - siam.in
Anthem Biosciences (ANTHEM.NS) Slips 0.61% to ₹884.95, Holding Firmly Above ₹840.7 Support - Short Setup Alerts  siam.in

Frequently Asked Questions About Anthem Biosciences

How many FDA inspections does Anthem Biosciences have on record?
CDMO Signal tracks 1 FDA inspection for Anthem Biosciences, sourced from the FDA inspection database. See the full inspection history above.
Has Anthem Biosciences received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Anthem Biosciences.
Does Anthem Biosciences have a CDMO Signal Score?
Not yet. Anthem Biosciences is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Anthem Biosciences for a manufacturing program?
Use the free AI matchmaker to compare Anthem Biosciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs →

Similar CDMOs

Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
Neuland Laboratories
Hyderabad, Telangana, India
Small Molecule API, Peptides & Oligos
Aragen Life Sciences
India
Small Molecule API, Biologics
Cohance Lifesciences
India
Small Molecule API, ADC / Bioconjugation, Peptides & Oligos
Cadila Pharmaceuticals (CDMO-CMO)
Ahmedabad, Gujarat, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Biologics

Compare Anthem Biosciences with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Anthem Biosciences
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.